Sort
21,453 grants matching “tuberculosis”
REAL-TIME PCR WITH MOLECULAR BEACONS
$135,726Yeshiva University · S10 · FY2000 · RR
Program/Project Administrative
$135,688William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2013 · AI
Core B. Biochemistry and Enzymology
$135,614James C Sacchettini · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Therapeutic Strategies for HIV Disease
$135,606University Of California San Francisco · K24 · FY2003 · AI
Coping With HIV/AIDS in Tanzania
$135,521Kathryn Whetten · Duke University · R01 · FY2012 · MH
Conditionally replicating Mycobacterium tuberculosis vaccines
$135,518Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
IMPILO: Investigating novel 6-Month regimens for RR-TB in Pregnancy and Lactation
$135,502Marian Loveday · Medical Research Council Of South Africa · R01 · FY2024 · AI
Simulation Modeling of Hepatitis B Virus Elimination Strategies in Cote d'Ivoire
$135,484Amir Mohareb · Massachusetts General Hospital · K01 · FY2023 · AI
Research Training in Infections and Immunity
$135,466David John Tweardy · Baylor College Of Medicine · T32 · FY2011 · AI
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease
$135,432Akshay Nitin Gupte · Johns Hopkins University · K99 · FY2021 · AI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents
$135,431Erick Strauss · Stellenbosch University · R01 · FY2020 · AI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
$135,414John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
An implementation science approach to the design and evaluation of tuberculosis self-testing
$135,337Yeon Soo Baik · Johns Hopkins University · K01 · FY2025 · HL
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease
$135,300Akshay Nitin Gupte · Johns Hopkins University · K99 · FY2020 · AI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation
$135,257April Pettit · Vanderbilt University · K08 · FY2014 · AI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation
$135,257April Pettit · Vanderbilt University Medical Center · K08 · FY2016 · AI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation
$135,257April Pettit · Vanderbilt University · K08 · FY2015 · AI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation
$135,257April Pettit · Vanderbilt University · K08 · FY2013 · AI
Teens on TB Treatment: Predicting Adherence through Clinical Decision Analysis
$135,127Silvia Shinpei Chiang · Rhode Island Hospital · K01 · FY2018 · TW
HIV and Perinatal Depression in Brazil
$135,023Judith Karen Bass · Johns Hopkins University · R21 · FY2008 · TW
Framework Program for Global Health at Yale University
$135,000Robert D Dubrow · Yale University · R25 · FY2010 · TW
HOST AND MICROBIOLOGICAL DETERMINANTS OF INFECTIOUSNESS IN PATIENTS WITH DRUG SEN
$135,000Keertan Unkha Dheda · University Of Cape Town · R01 · FY2014 · AI
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$135,000Weill Medical College Of Cornell Univ · D43 · FY2004 · TW
Washington Obstetric-Fetal Pharmacology Research Unit
$135,000Menachem Miodovnik · Georgetown University · U10 · FY2008 · HD
Framework Program for Global Health at Yale University
$135,000Robert D Dubrow · Yale University · R25 · FY2009 · TW